You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 10, October 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dementias
 •Neurogenetics
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Case of Dementia Parkinsonism Resembling Progressive Supranuclear Palsy Due to Mutation in the Tau Protein Gene

Paola Soliveri, MD; Giacomina Rossi, PhD; Daniela Monza, MD; Fabrizio Tagliavini, MD; Sylvie Piacentini, PhD; Alberto Albanese, MD; Orso Bugiani, MD; Floriano Girotti, MD

Arch Neurol. 2003;60:1454-1456.

Background  Few cases of frontotemporal dementia parkinsonism (FTDP-17) have been described in the literature. To our knowledge, this is the first Italian case.

Objective  To report a case of FTDP linked to chromosome 17, exhibiting progressive supranuclear palsy on initial examination.

Patient  A 50-year-old woman had a 4-year history of behavior changes associated with slowly progressive mental decay and parkinsonism, with poor balance, supranuclear vertical gaze palsy, and bradykinesia. The symptoms were not responsive to dopaminergic therapy. Her father had died at age 46 years after a 7-year history of parkinsonism, and her brother, diagnosed as having progressive supranuclear palsy, died at age 45 years.

Results  Magnetic resonance imaging showed mild midbrain atrophy, results of an electroencephalogram were normal, and cognitive evaluation showed moderate cognitive impairment, especially evident in the executive and attentional functions. Genetic testing revealed a tau gene mutation at codon 279 (AAT->AAG) of exon 10.

Conclusion  Exon 10 mutations (including the N279K mutation) that result in overproduction of the tau isoform with 4 microtubule binding motifs seem to be associated with a mainly parkinsonian phenotype at disease onset.


From the Divisions of Neurology I (Drs Soliveri, Monza, Piacentini, Albanese, and Girotti) and Neuropathology-Neurology V (Drs Rossi, Tagliavini, and Bugiani), Istituto Neurologico Nazionale Carlo Besta, Milan, Italy.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New Genes, New Dilemmas: FTLD Genetics and Its Implications for Families
Goldman et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:507-515.
ABSTRACT  

The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model
Dawson et al.
J. Neurosci. 2007;27:9155-9168.
ABSTRACT | FULL TEXT  

Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy
Paviour et al.
Brain 2004;127:2441-2451.
ABSTRACT | FULL TEXT  

Haplotype-Phenotype Correlations in Kindreds With the N279K Mutation in the Tau Gene
Woodruff et al.
Arch Neurol 2004;61:1327-1327.
FULL TEXT  

Haplotype-Phenotype Correlations in Kindreds With the N279K Mutation in the Tau Gene--Reply
Girotti
Arch Neurol 2004;61:1327-1327.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.